Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance - Test2 - elhamkhani - TriplyDB

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

http://www.wikidata.org/entity/Q28255243

about

Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types Treatment of hepatitis C in children: a systematic review Interferon lambda: a new sword in cancer immunotherapy A new insight into hepatitis C vaccine development IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance Hepatitis C genotype 6: A concise review and response-guided therapy proposal Vaccination for hepatitis C virus: closing in on an evasive target A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients Innate immunity evasion by Dengue virus Hepatitis C virus protease inhibitor-resistance mutations: our experience and review An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Education and personalized genomics: deciphering the public’s genetic health report Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms Hepatitis C Viral Infection in Children: Updated Review Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?KASL clinical practice guidelines: management of hepatitis C Recent advances in understanding hepatitis C Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections Treating hepatitis C - what's new?Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis Natural killer cells in hepatitis C: Current progress Chronic hepatitis C: This and the new era of treatment Human genetic basis of interindividual variability in the course of infection Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets Genetic background in nonalcoholic fatty liver disease: A comprehensive review The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans NK cell function and receptor diversity in the context of HCV infection Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies Interferon-λ: Immune Functions at Barrier Surfaces and Beyond Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection Natural history and clinical response: "it's the virus, stupid, or is it the host?"The chemokine superfamily revisited Regulation of hepatic innate immunity by hepatitis C virus Personalized medicine and human genetic diversity

P2860

Q21131160-567DCD2C-031D-4DA6-817B-10D323E5910E Q21136318-C436F060-F836-4219-9C44-A90CD3E52C2A Q21296797-E0AFDDAB-A25D-45CD-BFB2-CB75E2957FE9 Q21296858-DD7F8FAE-A2E2-4121-A911-91C96DB1EE6F Q22121973-3D324B6E-F710-45B3-9976-D6E313D7C40D Q22305417-6AC1BDA4-AF2F-4BB2-94F4-8E994D0ED6A0 Q22305922-3EF51DF9-5917-43B0-8531-9A3C2E562DE4 Q24307721-20DDE23D-7FF1-49F1-A42C-8B822F6B9C04 Q24596340-35AAD7E5-5F25-49CB-AB6A-4975A9F69F32 Q24596652-F2A5EF5B-C901-4260-AFB9-15596A9093F8 Q24611884-F81B7E99-EB0D-4ED2-BE4A-05E5FE57B558 Q24624237-19163C1F-48EF-4643-B680-3C88468D3011 Q24627203-171929F9-AA6F-4814-A95D-E1DA13B6F346 Q24628717-A4CE3644-47D2-47B5-BD3E-4EB161120A45 Q24632766-B6C97632-E364-4AD4-BAF3-EAB67C5D3A46 Q24648414-CB6013D9-A69D-4D9C-A61D-4D24A504ABEE Q26738545-AF9E0E70-0361-4ECD-AAA2-103C34E760EC Q26738856-FA620119-AA06-403C-9038-6FDC8283D4FB Q26745769-EFDB7682-2497-484D-9A37-7D83EB7F71D5 Q26746563-98B660D7-1595-40AA-BA60-F8A5529DDB81 Q26749249-068CBCEC-2ABE-4AD0-A806-4B152325277C Q26752471-9E999D20-2FAC-4372-935F-E280A936E646 Q26766136-88404145-94C4-4B17-8E35-39CB1B79D4F6 Q26768628-B9D6329E-811B-4E05-A846-25382BA15FEC Q26769646-6C82EFBF-9247-4088-A53A-B36CDBB66A49 Q26771458-63C0B0BF-2B9E-411A-85BB-04DEE932F1EF Q26773264-F438F79C-CD80-4EE7-AF69-043F35460107 Q26775011-1559D02F-A04F-42A6-A04D-25CD1A7CEC4C Q26775894-05040BA9-B369-488E-BA18-535690F0086F Q26777195-EE0133FF-7663-4295-AE51-15C60B31AA3C Q26780248-E6020673-7FD7-4F87-8158-33C574DBB412 Q26781379-73DE6405-0592-4C5B-9CFB-F0893921108B Q26781537-37CADC88-76E5-4675-AED8-B77D11A1B5DC Q26782009-03DB77D2-7963-402D-AEFB-4B75FD041C28 Q26801049-FA841D51-E3B7-4DB4-A146-687DBE350DBA Q26801381-763B2D9C-2C00-4419-9BAE-86E9DA18E9BC Q26824094-4D641890-4B72-4E5B-B522-6858DADD0515 Q26824492-50550FDA-303A-41E4-91D0-106B13D39A0D Q26824743-929AF170-F58C-470D-9D6C-8FC41FC2E29B Q26824838-03F733F6-7E67-4AA5-906E-258C42E06D87

P2860

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

http://www.wikidata.org/entity/Q28255243

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@ast

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@en

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@nl

type

label

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@ast

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@en

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@nl

prefLabel

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@ast

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@en

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@nl

P1433

Q28255243-BADB74D1-209B-4C81-B0DB-2D84B13C0A34

P1476

Q28255243-10DF3EBB-7ACC-4E23-9260-5F500D3EBA9C

P2093

Q28255243-06F1549A-68A5-4A5D-A286-2C191E97B243

Q28255243-61EF4D9C-9219-41F8-9FBF-18E6C67D65C3

Q28255243-81A3E3AF-CFA1-4FF1-97E7-AEBAD4BA48D3

Q28255243-92EEA433-C93B-46F4-A864-88C0A838CAA9

Q28255243-970FD4E8-7ADB-4626-B3FC-76556B8C8723

Q28255243-A6DA156C-9AC4-4EBF-8BEA-2C2C8B2E94EB

Q28255243-B0C8746D-03F6-4207-A3FA-4A816F16E427

Q28255243-B3EE5D00-2CF8-4BCC-BCFC-A4C5FC23F790

Q28255243-D24C9B83-2F3C-41D2-A812-60F65E800BBB

Q28255243-F2F048A9-2F47-4863-9159-1DF20C9CA4D1

P2888

Q28255243-1878FB30-F20D-402C-B257-803780816C5C

P304

Q28255243-4FAB1ACC-2631-4A44-B066-AEC0D6A954CD

P31

Q28255243-AD8009BA-176E-41DF-B907-788849CEE9DB

P3181

Q28255243-FF2A2589-D42F-4859-A9CF-54A72DCEAFB1

P356

Q28255243-C9E38FDF-C7FF-40CA-9F09-8AFC29005881

P407

Q28255243-7720AF0E-968A-41FA-A9D6-EBD3AE7E6512

P433

Q28255243-815653FC-B636-4F19-AC6C-CAF2EAAACF9C

P478

Q28255243-C1AEF96D-45C7-4313-94E6-F9A764C86D13

P50

Q28255243-8831C7B3-3F52-4C7B-A171-21AE62D877C2

P577

Q28255243-B1A7B722-B330-46FE-837C-D793FCED3F3C

P5875

Q28255243-F562DF13-5527-47E9-B251-DDAB54F78C6E

P6179

Q28255243-29DC2388-9045-407C-88CF-D47491290C03

P698

Q28255243-D557398A-8F78-4279-B1D2-075CB06A1A22

P921

Q28255243-dfebd2cb-4b7c-c0f3-896c-78e383947194

P3181

P356

P1433

P1476

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

@en

P2093

Alexander J Thompson

http://www.w3.org/2001/XMLSchema#string

Andrew J Muir

http://www.w3.org/2001/XMLSchema#string

Arthur H Bertelsen

http://www.w3.org/2001/XMLSchema#string

David B Goldstein

http://www.w3.org/2001/XMLSchema#string

Dongliang Ge

http://www.w3.org/2001/XMLSchema#string

Erin L Heinzen

http://www.w3.org/2001/XMLSchema#string

Jason S Simon

http://www.w3.org/2001/XMLSchema#string

John G McHutchison

http://www.w3.org/2001/XMLSchema#string

Kevin V Shianna

http://www.w3.org/2001/XMLSchema#string

Mark Sulkowski

http://www.w3.org/2001/XMLSchema#string

P2888

P304

399-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

214872

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE08309

http://www.w3.org/2001/XMLSchema#string

P407

P433

7262

http://www.w3.org/2001/XMLSchema#string

P478

461

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26745753

http://www.w3.org/2001/XMLSchema#string

P6179

1019337542

http://www.w3.org/2001/XMLSchema#string

P698

19684573

http://www.w3.org/2001/XMLSchema#string

P921